Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 26, 2021 07:30 ET | Source: Humacyte, Inc.

Humacyte Receives 2021 Life Sciences Award from Triangle Business Journal

DURHAM, N.C., May 26, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale,...
May 22, 2021 15:50 ET | Source: Humacyte, Inc.

Humacyte Announces Presentation by Principal Investigator Highlighting Clinical Experience with HAVs at Vascular Access Society of the Americas 2021 Spring Conference

DURHAM, N.C., May 22, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale,...
May 21, 2021 07:30 ET | Source: Humacyte, Inc.

Humacyte Presents Advances in Whole-Lung Engineering

Laboratory and pre-clinical models of whole-lung engineering inform roadmap for building a functional lung alveolus, which is the key building block for making a functional lungData presented at 38th...
May 19, 2021 16:30 ET | Source: Humacyte, Inc.

Humacyte Appoints Dale Sander as Chief Financial Officer

DURHAM, N.C., May 19, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale,...
May 06, 2021 07:30 ET | Source: Humacyte, Inc.

Humacyte Leadership and Investigators to Present at Five Scientific Events in May

DURHAM, N.C., May 06, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale,...
April 21, 2021 08:00 ET | Source: Humacyte, Inc.

Humacyte Announces Positive Long-Term Follow-Up Data from Phase 2 Vascular Access Trial

Five-year outcomes demonstrate HAV retained durability and structural integrity, potentially offering a safe and viable option for long-term hemodialysisLong-term explant samples demonstrate...
April 14, 2021 07:30 ET | Source: Humacyte, Inc.

Humacyte Secures $50 Million Debt Facility with Silicon Valley Bank

DURHAM, N.C., April 14, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale,...
March 23, 2021 07:30 ET | Source: Humacyte, Inc.

Humacyte CEO Dr. Laura Niklason and Alpha Healthcare CEO Rajiv Shukla to Present at CED Venture Connect 2021 Online Summit

DURHAM, N.C., March 23, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale,...
March 11, 2021 07:30 ET | Source: Humacyte, Inc.

Humacyte to Present at Oppenheimer 31st Annual Healthcare Conference

DURHAM, N.C., March 11, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale,...
March 05, 2021 07:30 ET | Source: Humacyte, Inc.

Humacyte to Present Long-Term Follow-Up Data from Phase 2 Vascular Access Trial at Charing Cross (CX) International Symposium 2021

DURHAM, N.C., March 05, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale,...